UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Serum markers of B-cell activation in pregnant women with atopic asthma

Martins, C; Lima, J; Cambridge, G; Ângelo-Dias, M; Leandro, M; Miguel Borrego, L; (2021) Serum markers of B-cell activation in pregnant women with atopic asthma. American Journal of Reproductive Immunology , 86 (2) , Article e13414. 10.1111/aji.13414. Green open access

[thumbnail of Cambridge_American J Rep Immunol - 2021 - Martins - Serum markers of B‐cell activation in pregnant women with atopic asthma.pdf]
Preview
Text
Cambridge_American J Rep Immunol - 2021 - Martins - Serum markers of B‐cell activation in pregnant women with atopic asthma.pdf

Download (1MB) | Preview

Abstract

Problem: As maternal atopy represents a risk factor for the development of atopy in offspring, we aimed to assess how pregnancy affects B‐cell activation markers in women with atopic asthma and whether they correlate with risk manifestations for allergy in newborns from mothers with atopic asthma. / Method of Study: Pregnant women with atopic asthma (AP) in the third trimester of gestation and nonpregnant women with atopic asthma (ANP) were prospectively recruited and compared to respective healthy counterparts (HP and HNP). All pregnant women were also assessed during the postpartum period until 6 weeks after delivery (HP/PP and AP/PP). Newborns were clinically evaluated at the age of 6 months. Peripheral blood samples were taken from each woman at each time point. Soluble CD23 (sCD23), B‐cell activating factor (BAFF), IgA, IgG, IgM, kappa (κ), and lambda (λ) free light chains (FLC) were quantified in serum samples. / Results: The AP group presented increased sCD23 (p < 0.05) and BAFF (p < 0.001) levels compared to the ANP group and even higher levels of sCD23 during the postpartum period (p < 0.001). Moreover, the cutoffs of 6.74 g/L for IgG (sensitivity 90.9%, specificity 77.8%) and of 11.30 mg/L for λ FLC (sensitivity 81.8%, specificity 88.9%) in the AP group were predictive factors for the manifestation of allergy in their offspring. / Conclusions: After delivery, the dynamics of sCD23 and BAFF changed significantly in the AP group. Furthermore, we found novel predictive factors for allergy manifestations in the children of these women, with potential clinical application.

Type: Article
Title: Serum markers of B-cell activation in pregnant women with atopic asthma
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/aji.13414
Publisher version: https://doi.org/10.1111/aji.13414
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Allergy, asthma, B‐cell activating factor, free light chain, immunoglobulins, postpartum, pregnancy, soluble CD23
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10127809
Downloads since deposit
22Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item